Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities

被引:51
作者
Blass, JP [1 ]
机构
[1] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA
关键词
Alzheimer disease; Alzheimer dementia; causes;
D O I
10.1016/S0197-4580(02)00036-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Much of the controversy about the "amyloid cascade hypothesis" may reflect unrecognized differences in the use of language, including the use of the word "cause." This commentary proposes that the term Alzheimer disease refer to the neuropathological entity and the term Alzheimer dementia to clinical dementia in people who also have Alzheimer neuropathology. The ultimate causes of Alzheimer disease are proposed to be aging, environmental stresses, and genetic predispositions. The fundamental cause of Alzheimer dementia is proposed to be Alzheimer disease, i.e. the neurobiological abnormalities in Alzheimer brain. The neurobiology of Alzheimer disease includes changes that may initially be adaptive but can become excessive and thereby harmful; they include increased expression of APP with accumulation of potentially damaging peptides such as Abeta, inflammation, and increased ROS activity. The neurobiological abnormality that is the proximate cause of Alzheimer dementia appears to be decreases in cerebral metabolic rate. Decreased metabolism occurs not only in. this but in essentially all dementias, and impairing brain metabolism induces neuropsychological deficits characteristic of dementias. The immediate cause of Alzheimer dementia is proposed to be deficiencies in signaling, both intracellular and intercellular (neurotransmission), that follow directly from the decrease in cerebrometabolic rate. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:1077 / 1084
页数:8
相关论文
共 58 条
  • [31] Autoantibodies to amyloid-β and Alzheimer's disease
    Hyman, BT
    Smith, C
    Buldyrev, I
    Whelan, C
    Brown, H
    Tang, MX
    Mayeux, R
    [J]. ANNALS OF NEUROLOGY, 2001, 49 (06) : 808 - 810
  • [32] Kalaria RN, 2000, ANN NY ACAD SCI, V903, P1
  • [33] Neurodegenerative tauopathies
    Lee, VMY
    Goedert, M
    Trojanowski, JQ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 1121 - 1159
  • [34] GLUCOSE ENHANCEMENT OF MEMORY IN PATIENTS WITH PROBABLE SENILE DEMENTIA OF THE ALZHEIMERS TYPE
    MANNING, CA
    RAGOZZINO, ME
    GOLD, PE
    [J]. NEUROBIOLOGY OF AGING, 1993, 14 (06) : 523 - 528
  • [35] Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease
    Mattson, MP
    Barger, SW
    Furukawa, K
    Bruce, AJ
    WyssCoray, T
    Mark, RJ
    Mucke, L
    [J]. BRAIN RESEARCH REVIEWS, 1997, 23 (1-2) : 47 - 61
  • [36] MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50
  • [37] OXIDATIVE DAMAGE TO MITOCHONDRIAL-DNA IS INCREASED IN ALZHEIMERS-DISEASE
    MECOCCI, P
    MACGARVEY, U
    BEAL, MF
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (05) : 747 - 751
  • [38] A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients
    Mohs, RC
    Doody, RS
    Morris, JC
    Ieni, JR
    Rogers, SL
    Perdomo, CA
    Pratt, RD
    [J]. NEUROLOGY, 2001, 57 (03) : 481 - 488
  • [39] Absence of vascular dementia in an autopsy series from a dementia clinic
    Nolan, KA
    Lino, MM
    Seligmann, AW
    Blass, JP
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (05) : 597 - 604
  • [40] Oxidative damage is the earliest event in Alzheimer disease
    Nunomura, A
    Perry, G
    Aliev, G
    Hirai, K
    Takeda, A
    Balraj, EK
    Jones, PK
    Ghanbari, H
    Wataya, T
    Shimohama, S
    Chiba, S
    Atwood, CS
    Petersen, RB
    Smith, MA
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (08) : 759 - 767